Klona Biotech
Klona Biotech, founded in 2025 and based in London, is a bioprinting startup in IndieBio New York's 2025 H2 cohort.
About
Klona Biotech, founded in 2025 and based in London, is a bioprinting startup in IndieBio New York's 2025 H2 cohort. It builds an integrated software, hardware and materials platform that uses fibre-reinforced gel-textile composites to manufacture strong, cell-compatible personalised implants, starting with ligament and tendon repair and expanding to meniscus and other patient-specific implants.
Capital graph
Founders / team· 2
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Klona Biotech
Klona Biotech, founded in 2025 and based in London, is a bioprinting startup in IndieBio New York's 2025 H2 cohort.
—
United States
BusinessLatest roundTotal raisedDate- restor3d
Patient-specific orthopedic implants, combining 3D printing, AI preoperative planning and rapid surgical design tools
Undisclosed · $104M · 2025-08
$104M - Nervonik
Implantable peripheral nerve stimulation devices using electrical signals and real-time sensing for personalized chronic pain treatment
Series B · $53M · 2026-05
$53M - Mira
Connected at-home hormone monitor, disposable test sticks, AI analysis app and online hormone health clinic for women trying to conceive…
$5M
$5M
China
BusinessLatest roundTotal raisedDate- 美柏生物
R&D and manufacturing of human-derived extracellular matrix (ECM) regenerative medicine materials, covering aesthetic skin repair…
Series B · 2026-09
— - iNAP Sleep
Brand operation of iNAP oral negative-pressure therapy for obstructive sleep apnea (OSA)…
— - Kossel Medtech
R&D and manufacturing of pan-vascular interventional devices (peripheral intervention, coronary, electrophysiology, core raw materials)…
Series C · 2026-09
—
Europe
BusinessLatest roundTotal raisedDate- MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation…
Undisclosed · 2026-10
— - XRlabs
XRlabs SIM (CT/MRI to 3D digital twins for surgical rehearsal) and SurgicalOS (real-time AI video and instrument tracking) for hospitals and surgeons
Seed · 2026-10
— - Implicity
Data aggregation and AI risk alert platform for remote monitoring of cardiac implantable electronic devices (CIEDs)
Undisclosed · 2026-09
—
Other / unspecified
BusinessLatest roundTotal raisedDate- CustoMED
AI and 3D printing to produce patient-specific orthopedic surgical tools and implants
Seed · $6M · 2025-11
$6M - LEESOL
Brainwave-synchronizing wearables for sleep and mental health (Sleepisol series, blissol, DAYZER) with AI biosignal analysis
Series A · $1.1B · 2026-02
$1.1B - IMeditech
R&D and manufacturing of electrospun nanofiber wound care devices, vascular stents, catheters and neurointerventional devices…
$1.1B
$1.1B
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.